As the home of EastCann, FOUR54, IRIS Labs, Origin Coast, and MSIKU, AMI leverages a diverse portfolio of cultivars and industry-leading cultivation practices to deliver bold, exciting cannabis experiences. Each cultivar at AMI is grown in a tightly controlled environment, guided by rigorous quality assurance protocols. Every batch is third-party lab tested by Health Canada–approved laboratories for cannabinoid potency (THC, CBD), terpene profiles, and the absence of microbial or chemical contaminants. Each cultivar at AMI is grown in a tightly controlled environment, guided by rigorous quality assurance protocols. Every batch is third-party lab tested by Health Canada–approved laboratories for cannabinoid potency (THC, CBD), terpene profiles, and the absence of microbial or chemical contaminants.
| Website | https://atlanticann.com/ |
| Employees | 25 (14 on RocketReach) |
| Founded | 2014 |
| Industry | Pharmaceutical Manufacturing |
Looking for a particular AMI employee's phone or email?
Michael Coggins is the Shareholder and Partner of AMI.
14 people are employed at AMI.
AMI is based in Lower Sackville, Nova Scotia.